CTLA4	Cytotoxic T lymphocyte antigen 4
ECOG PS	Eastern Cooperative Oncology Group Performance Status
EMA	European Medicines Agency
FDA	Food and drug administration
HLA	Human leukocyte antigen
LIPI	Pulmonary immune prognostic index
PFS	Progression-free survival
ORR	Overall response rate
OS	Overall survival
PD-L1	Programmed cell death ligand 1
TCR	T cell receptor
TIM3	T-cell immunoglobulin mucin 3
TTField	Alternating electric field therapy
VISTA	V-domain Ig-containing suppressor of T cell activation